Core Viewpoint - Hengan International (01044) announced a final dividend of RMB 0.7 per share to be distributed on June 5, 2026 [1] Group 1 - The company will distribute a final dividend of RMB 0.7 per share [1]

Core Viewpoint - The company reported a revenue of 23.069 billion RMB for the year ending December 31, 2025, reflecting a year-on-year increase of 1.8%, with a profit attributable to equity holders of 2.535 billion RMB, up 10.3% year-on-year [1] Group 1: Financial Performance - The company achieved a gross profit of approximately 7.806 billion RMB for 2025, representing a year-on-year increase of about 6.6% [2] - The overall gross margin improved to approximately 33.8% in 2025, compared to 32.3% in 2024, due to reduced promotional spending on paper towels and a recovery in sales of hygiene products [2] - The basic earnings per share were reported at 2.227 RMB, with a proposed final dividend of 0.7 RMB per share [1] Group 2: Sales Channels and Product Development - The company is actively developing e-commerce and new retail channels, with sales from these channels increasing by 10.1% year-on-year, accounting for 36.9% of total sales [1] - The company is focusing on high-end product development, with strong sales in premium product lines such as "Tianshan Velvet Cotton" sanitary napkins and "Q•MO" high-end diapers, contributing to improved profitability [1] - New product launches, including the "Cranberry A+" organic cotton sanitary napkin and the "Towards the Wild" high-end tissue series, align with the trend of value consumption, injecting new momentum into overall revenue [1]

Core Viewpoint - Hengan International (01044) reported a revenue of RMB 23.069 billion for the year ending December 31, 2025, representing a year-on-year increase of 1.8% and a profit attributable to equity holders of RMB 2.535 billion, up 10.3% year-on-year, with a proposed final dividend of RMB 0.7 per share [1] Group 1: Revenue and Profit Performance - The company achieved a revenue of RMB 23.069 billion, reflecting a 1.8% increase compared to the previous year [1] - Profit attributable to equity holders reached RMB 2.535 billion, marking a 10.3% year-on-year growth [1] - Basic earnings per share were reported at RMB 2.227 [1] Group 2: Sales Channels and Growth Strategies - The company is actively developing e-commerce and new retail channels, with sales from these segments increasing by 10.1%, accounting for 36.9% of total sales, up from 34.1% in 2024 [1] - Traditional channels are being explored for new growth points, particularly in the sanitary products market [1] - The company is focusing on product premiumization and diversification to meet higher consumer demands for functionality and added value [1] Group 3: Product Performance and Market Trends - Key high-end products, including the "Tianshan Velvet Cotton" sanitary napkin series and "Q MO" high-end diapers, maintained strong sales momentum, enhancing profitability [1] - New product launches, such as the "Cranberry A+" organic cotton sanitary napkin and the "Born Wild" high-end tissue series, align with the "value consumption" trend, injecting new growth into overall revenue [1] Group 4: Gross Margin and Future Outlook - The overall gross profit for 2025 increased by approximately 6.6% to around RMB 7.806 billion, compared to RMB 7.325 billion in 2024 [2] - The gross margin improved to approximately 33.8% in 2025, up from 32.3% in 2024, due to reduced promotional spending on tissues and a recovery in sanitary product sales [2] - The company anticipates stable gross profit in 2026, with precise sales expense allocation and continued growth in high-end, high-margin products to mitigate the impact of raw material price fluctuations [2]

Core Viewpoint - Hengan International (01044.HK) reported a revenue of RMB 23.069 billion for the fiscal year ending December 31, 2025, reflecting a year-on-year growth of 1.8%, with a net profit attributable to shareholders of RMB 2.535 billion, up 10.3% [1][2]. Group 1: Financial Performance - The group's main business revenue, including tissue and hygiene product sales, reached RMB 20.740 billion, marking a 1.9% increase year-on-year [1]. - Basic earnings per share were RMB 2.227, with a proposed final dividend of RMB 0.70 per share [1]. - Overall gross profit increased by approximately 6.6% to around RMB 7.806 billion, with an improved gross margin of about 33.8% for the year [4]. Group 2: Market Dynamics - The domestic consumer goods market is experiencing intensified competition, particularly in the tissue industry, leading to the consolidation of smaller enterprises [2]. - Despite high margins in the hygiene products market, ongoing price competition remains a challenge [2]. Group 3: Strategic Initiatives - The company is adapting to industry trends by focusing on personal care product upgrades and expanding new retail channels, employing a stable pricing strategy and product premiumization [2][3]. - E-commerce and new retail sales grew by 10.1%, accounting for 36.9% of total sales, driven by the demand for immediate supply of daily necessities [3]. - The introduction of high-end products, such as the "Tianshan Velvet Cotton" sanitary napkin series and the "Q ? MO" premium diaper series, has contributed to strong sales momentum and enhanced profitability [3]. Group 4: Future Outlook - The company anticipates continued pressure on the operating environment in 2026, but expects steady growth in tissue sales to bolster profit resilience [2]. - Strategic allocation of sales expenses and the growth of high-margin premium products are expected to mitigate the impact of raw material price fluctuations on gross profit [4].

| EF001 | | --- | EF001 免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | | --- | --- | | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | 股票發行人現金股息公告 | | | 發行人名稱 | 恒安國際集團有限公司 | | 股份代號 | 01044 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 截至二零二五年十二月三十一日止之末期股息 | | | 公告日期 | 2026年3月17日 | | 公告狀態 | 新公告 | | 股息信息 | | | 股息類型 | 末期 | | 股息性質 | 普通股息 | | 財政年末 | 2025年12月31日 | | 宣派股息的報告期末 | 2025年12月31日 | | 宣派股息 | 每 股 0.7 RMB | | 股東批准日期 | 2026年5月18日 | | 香港過戶登記處相關信息 | | | 派息金額及公司預設派發貨幣 | 每 股 0.7935 ...

ANNUAL RESULTS 2025 Corporate Presentation March 2026 AGENDA Open Forum Financial Highlights Financial Highlights Business Review Outlook Priorities and Opportunities Near Term ◼ Hygiene Products Further consolidate leading position by expanding market share of upgrade and premium products and enhancing omni- channel layout ◼ Tissue Paper Revenue growth and market share expansion driven by product upgrade and premiumisation, and stable pricing strategy Capture the opportunities of industry consolidation Mid ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦 不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任 何損失承擔任何責任。 （於開曼群島註冊成立的有限公司） （股份代號：1044） http://www.hengan.com http://www.irasia.com/listco/hk/hengan 網址： 二零二五年十二月三十一日止年度業績公告 『追求健康，你我一起成長』 | 二零二五年年度業績財務摘要 | | | | | --- | --- | --- | --- | | 二零二五年 | | 二零二四年 | 變動 | | 人民幣千元 | 人民幣千元 | | % | | 收入 | 23,068,869 | 22,669,215 | 1.8% | | 主營業務收入（包括紙巾及衛生用品收入） | 20,739,891 | 20,361,041 | 1.9% | | 毛利率(%) | 33.8% | 32.3% | | | 經營利潤 | 3,484,096 | 3,354,591 | 3.9% | | 公司權益持有人應佔利潤 ...

格隆汇3月2日丨恒安国际(01044.HK)宣布，公司将于2026年3月17日(星期二)举行董事会会议，藉以批 准之事项包括(但不限于)公司及其附属公司截至2025年12月31日止的年度业绩及考虑派发末期股息。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 承董事會命 恒安國際集團有限公司 主席 施文博 （於開曼群島註冊成立的有限公司） （股份代號：1044） http://www.hengan.com http://www.irasia.com/listco/hk/hengan 網址： 董事會會議召開日期 恒安國際集團有限公司（「本公司」）之董事會（「董事會」）宣佈，本公司將於二零二六 年三月十七日（星期二）舉行董事會會議，藉以批准之事項包括（但不限於）本公司及 其附屬公司截至二零二五年十二月三十一日止之年度業績及考慮派發末期股息。 香港，二零二六年三月二日 於本公告日期，董事會包括執行董事施文博先生、許清流先生、許大座先生、施煌 劍先生、許清池先生、李偉樑先生和許文默先生；及獨立非執行董事黃英琦女士、 何貴清先生、保羅希爾先生和陳闖先生。 ...

截至月份: 2026年2月28日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 恒安國際集團有限公司 呈交日期: 2026年3月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01044 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,000,000,000 | HKD | | 0.1 | HKD | | 300,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 3,000,000,000 | HKD | | 0.1 | HKD | | 300,000,000 | 本月底法定/註冊股本總額： HKD 300,000,000 FF301 股份發行人及根據《上市規則》 ...